The K666N mutation in SF3B1 is associated with increased progression of MDS and distinct RNA splicing

Blood Adv. 2020 Apr 14;4(7):1192-1196. doi: 10.1182/bloodadvances.2019001127.

Abstract

  1. The K666N mutation of SF3B1 has distinct clinicopathologic features in MDS.

  2. The K666N mutation of SF3B1 has a distinct RNA splicing profile.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Mutation
  • RNA Splicing Factors / genetics
  • RNA Splicing Factors / metabolism
  • RNA Splicing*

Substances

  • RNA Splicing Factors